Follow the WAVERLEY PHARMA INC. stock price and the full management transaction log of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Market capitalisation: €810k. The latest transaction was disclosed on 19 August 2026 (55 - Expiration of warrants). Among the most active insiders: Friesen, Albert David. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Waverley Pharma Inc. is a company focused on the development of pharmaceutical products. It is listed on the Toronto Stock Exchange under the symbol XTSE.